[Federal Register Volume 82, Number 142 (Wednesday, July 26, 2017)]
[Notices]
[Page 34695]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15688]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: AMRI
Rensselaer, Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before September 25, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on March
30, 2017, AMRI Rensselaer, Inc., 33 Riverside Avenue, Rensselaer, New
York 12144 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana.......................... 7360 I
Tetrahydrocannabinols.............. 7370 I
Amphetamine........................ 1100 II
Lisdexamfetamine................... 1205 II
Methylphenidate.................... 1724 II
Pentobarbital...................... 2270 II
4-Anilino-N-phenethyl-4-piperidine 8333 II
(ANPP).
Codeine............................ 9050 II
Oxycodone.......................... 9143 II
Hydromorphone...................... 9150 II
Hydrocodone........................ 9193 II
Meperidine......................... 9230 II
Morphine........................... 9300 II
Fentanyl........................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture bulk controlled substances for use
in product development and for distribution to its customers.
In reference to drug codes 7360 (marihuana) and 7370 (THC), the
company plans to bulk manufacture these drugs as synthetics. No other
activities for these drug codes are authorized for this registration.
Dated: July 19, 2017.
Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-15688 Filed 7-25-17; 8:45 am]
BILLING CODE 4410-09-P